As the rollout of PATH‘s Total Access PATH Payment system continues, riders are quickly adopting the new tap-to-pay system. TAPP is an open-loop contactless payment system allowing customers to use ...
Bio-Path Holdings, Inc. has announced significant progress with its drug BP1001-A, which has shown potential as a treatment for obesity and Type 2 diabetes in recent preclinical studies. The research ...
HOUSTON, May 01, 2025 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (BPTH),, a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop a ...
Bio-Path Holdings, Inc. has announced a positive outlook for 2025, building on advancements made in 2024 in their clinical development pipeline, which includes targeted nucleic acid drugs for cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results